MedPath

Sodium nitroprusside

Generic Name
Sodium nitroprusside
Brand Names
Nipride, Nipride RTU, Nitropress
Drug Type
Small Molecule
Chemical Formula
C5FeN6O
CAS Number
15078-28-1
Unique Ingredient Identifier
169D1260KM

Overview

Nitroprusside serves as a source of nitric oxide, a potent peripheral vasodilator that affects both arterioles and venules (venules more than arterioles). Nitroprusside is often administered intravenously to patients who are experiencing a hypertensive emergency.

Background

Nitroprusside serves as a source of nitric oxide, a potent peripheral vasodilator that affects both arterioles and venules (venules more than arterioles). Nitroprusside is often administered intravenously to patients who are experiencing a hypertensive emergency.

Indication

For immediate reduction of blood pressure of patients in hypertensive crises, reduce bleeding during surgery, and for the treatment of acute congestive heart failure

Associated Conditions

  • Acute Heart Failure (AHF)
  • Hypertensive crisis
  • Intraoperative Blood Loss

FDA Approved Products

SODIUM NITROPRUSSIDE
Manufacturer:Armas Pharmaceuticals Inc.
Route:INTRAVENOUS
Strength:50 mg in 2 mL
Approved: 2021/05/13
NDC:72485-105
Sodium Nitroprusside
Manufacturer:Hainan Poly Pharm. Co., Ltd.
Route:INTRAVENOUS
Strength:0.2 mg in 1 mL
Approved: 2022/12/31
NDC:14335-133
Sodium Nitroprusside
Manufacturer:Dr.Reddy's Laboratories Inc.,
Route:INTRAVENOUS
Strength:50 mg in 2 mL
Approved: 2016/12/22
NDC:43598-587
NIPRIDE RTU
Manufacturer:EXELA PHARMA SCIENCES, LLC
Route:INTRAVENOUS
Strength:0.5 mg in 1 mL
Approved: 2018/07/20
NDC:51754-1006
Sodium Nitroprusside
Manufacturer:Hainan Poly Pharm. Co., Ltd.
Route:INTRAVENOUS
Strength:0.2 mg in 1 mL
Approved: 2022/12/31
NDC:14335-132

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath